Streetbeat News

Products Services

CRSR

Corsair (NASDAQ:CRSR) is set to acquire the Fanatec Sim Racing brand from Endor AG, with the acquisition expected to close within the week. Fanatec's 2023 sales were approximately $110 million.

Portfolio Pulse from Benzinga Newsdesk

September 16, 2024 | 1:05 pm

PL

Planet Labs Germany has signed a three-year contract with the German Space Agency to provide Earth observation data products and services. This partnership highlights Planet Labs' growing influence in the space data sector.

Portfolio Pulse from Benzinga Newsdesk

September 16, 2024 | 1:05 pm

SHPH

Shuttle Pharmaceuticals has expanded its Phase 2 clinical trial of Ropidoxuridine for glioblastoma treatment to two additional sites, totaling four centers ready for patient enrollment. The participating centers are UVA Cancer Center, John Theurer Cancer Center, AHN Cancer Institute, and Miami Cancer Institute.

Portfolio Pulse from Benzinga Newsdesk

September 16, 2024 | 1:03 pm

ACN

Accenture Federal Services has secured a $190 million contract from the U.S. Department of State to provide data and systems engineering support for PEPFAR, a program aimed at controlling the global HIV epidemic.

Portfolio Pulse from Benzinga Newsdesk

September 16, 2024 | 1:02 pm

TTOO

T2 Biosystems has received FDA clearance to market its T2Candida Panel for pediatric patients. This is the only test that can detect sepsis-causing Candida species directly from blood in 3-5 hours without the need for a blood culture. The panel can detect five Candida species responsible for 95% of U.S. bloodstream infections.

Portfolio Pulse from Benzinga Newsdesk

September 16, 2024 | 1:02 pm

ZNTL

The FDA has lifted the partial clinical hold on Zentalis Pharmaceuticals' azenosertib studies, allowing the company to resume enrollment in all ongoing clinical trials. This decision follows a comprehensive safety assessment after two deaths in a previous study. Zentalis plans to present further data later this year and remains on track with its 2024 data guidance.

Portfolio Pulse from Vandana Singh

September 16, 2024 | 1:00 pm

GEVO

Gevo has secured a U.S. patent for its Ethanol to Olefins (ETO) process, enhancing its intellectual property in bio-based renewable fuel and chemical production. The patent includes proprietary catalyst combinations designed to improve cost efficiency and yields.

Portfolio Pulse from Benzinga Newsdesk

September 16, 2024 | 12:56 pm

EPIX

ESSA Pharma's shares rose following the presentation of data on its prostate cancer therapy, Masofaniten, at ESMO 2024.

Portfolio Pulse from Benzinga Newsdesk

September 16, 2024 | 12:54 pm

NXTC

NextCure shares are trading lower following the announcement of results from its Phase 1b study of NC410.

Portfolio Pulse from Benzinga Newsdesk

September 16, 2024 | 12:51 pm